Connect with us

Business Partnerships

TILT Partners with CMW Media in a Bid to Boost CBD Brand Recognition

Published

on

TILT Partners with CMW Media in a Bid to Boost CBD Brand Recognition

TILT, a prominent public relations firm that operates on a global scale, has announced that it is partnering with CMW Media in a press release. CWM Media is also a public relations agency, but that focuses on CBD health and wellness products.

CWM Media announced in the press release about the partnership,

“The opportunity to partner with TILT Holdings is a major accomplishment for our company and meets our everlasting goal to work with businesses that are providing real, impactful solutions for the cannabis industry”

TILT decided to venture into the partnership due to its continued effort to promote more recognition for the firm’s subsidiaries and to generate communication and transparency by way of media coverage. As the press release explains, CWM Media “will position TILT as a company dedicated to providing value to all cannabis retailers through hardware infrastructure, technology, and more.” Despite the cannabis industry in medical marijuana and adult use states, cannabis remains illegal under federal law and is a schedule I drug.

As for CWM Media, it will provide TILT with a consistent stream of communication and media campaigns that are specifically geared toward the cannabis industry. It will also promote recognition of TILT’s portfolio of leading cannabis companies and brands.

Mark Scatterday the CEO of TILT Holdings, shared in the press release,

“From an operational and functionality standpoint, TILT is positioned better and stronger than we’ve ever been, and we want the world to know it. Our goal through the partnership with CMW Media is to educate the public on TILT’s ongoing successes and bring light to our subsidiary businesses through executed media campaigns and storytelling that demonstrates what sets us apart from everyone else in the industry.”

CMW Media will also use its public relations expertise to promote TILT’s story. TILT has a diverse asset base, team members who are talented, and it is positioned for profitability as well.

Andrew Hard, CMW Media’s CEO, shared in the press release,

“The opportunity to partner with TILT Holdings is a major accomplishment for our company and meets our everlasting goal to work with businesses that are providing real, impactful solutions for the cannabis industry.”

He added,

“We are excited to hit the ground running alongside TILT’s impressive, renewed executive team and to share with the cannabis industry and beyond what this impressive company has accomplished and their goals for the future.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.